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Abstract The molecular chaperone Cdc37 is thought to act in
part as a targeting subunit of the heat-shock protein 90 (Hsp90)
chaperone complex. We demonstrate here that Cdc37 is required
for activity of the kinase Ste11 in budding yeast. A cdc37 mutant
strain is defective in Ste11-mediated pheromone signaling and in
accumulation and functional maturation of the constitutively
active Ste11 version Ste11vN. Moreover, Cdc37, Ste11vN and
Hsp90 coprecipitate pairwise. Thus, Hsp90 and Cdc37 may
transiently associate with Ste11 to promote proper folding and/or
association with additional regulatory factors. Our results
establish Ste11 as the first endogenous Cdc37 client protein in
yeast.
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1. Introduction
cdc37 was initially discovered in the budding yeast Saccha-
romyces cerevisiae as a temperature-sensitive cell division cycle
(Cdc) mutation that arrests cells at Start in G1 at the non-
permissive temperature [1]. Why it does that and why the null
mutation is lethal [1,2] remains poorly understood. Genetic
interactions have been found between CDC37 and the genes
encoding the p34Cdc2-type cell cycle kinase homologs Cdc2 in
Drosophila [3] and Cdc28 in yeast [2,4], the kinases Mps1 [5]
and Kin28 [6], and the isoforms Hsc82 and Hsp82 of the
molecular chaperone heat-shock protein 90 (Hsp90) [7] in
yeast. Whereas biochemical interactions have not been re-
ported for these four proteins, the reduced levels and/or activ-
ities of Mps1 and Cdc28 in yeast strains with cdc37 mutations
might account for the observed defects in spindle pole body
duplication [5] and cell cycle progression [2].
In contrast to Drosophila and yeast, the vertebrate homolog
p50Cdc37 has been discovered by virtue of it being a 50 kDa
component of multisubunit complexes with pp60vÿsrc and oth-
er members of the Src kinase family [8^14], the kinases Cdk4
[15,16], Cdk6 [17] and Raf-1 [18,19]. These complexes also
contain Hsp90, which binds Cdc37 directly [20]. In vitro, yeast
Cdc37 has been demonstrated to be a molecular chaperone
[7]. Thus, work with a variety of organisms over the last
decade has led to the view that Cdc37 is a molecular chaper-
one that may have some speci¢city for protein kinases and
perhaps as a co-chaperone also direct Hsp90 to these sub-
strates (reviewed in [21^23]).
Yeast Cdc37 diverges from mammalian and Drosophila
p50Cdc37/Cdc37 quite considerably. Overall, it shares only
about 20% sequence identity at the amino acid level with
human Cdc37 with the highest conservation in the N-terminal
50 amino acids [15]. Several observations suggest that at least
some Cdc37 functions may be conserved between yeast and
multicellular organisms: (i) Drosophila CDC37 can comple-
ment a cdc37 yeast strain [3]; (ii) yeast CDC37 is required
for activity of vertebrate pp60vÿsrc expressed in yeast [24],
and (iii) its overexpression can rescue pp60vÿsrc activity in a
hsp90 mutant strain [7].
p50Cdc37/Cdc37 is required for sevenless signaling in Droso-
phila [3], and in mammalian cells for Raf-1 function and thus
for growth factor signaling to mitogen-activated protein ki-
nase (MAPK) [25]. We therefore wondered whether the Cdc37
function in MAPK pathways is conserved in the budding
yeast despite the sequence divergence. We set out to examine
the pheromone signaling pathway since it is one of those
MAPK pathways that are dependent on the Raf equivalent
Ste11 (reviewed in [26,27]), which we have previously shown
to require the Cdc37 co-chaperone Hsp90 [28]. Binding of
mating pheromone to transmembrane receptors elicits a series
of events including the sequential activation of the kinases
Ste11, Ste7 and Fus3, leading to morphological changes, a
cell cycle arrest in G1 and the expression of speci¢c genes in
preparation for mating. For the ¢rst time, we provide com-
bined genetic and biochemical evidence for an endogenous
Cdc37 function in yeast.
2. Materials and methods
2.1. Plasmids
The wild-type CDC37 open reading frame was obtained by PCR
ampli¢cation of yeast genomic DNA using the following oligos:
5P-CCTGGATCCAAGTCAAAAATGGCCATTGATTACTCT-3P
and 5P-TTTGAGCTCTAGATGCACGCTGCACCAGTAAAATAG-
CTA-3P. The BamHI-SacI cut PCR product and a SacI-BglII frag-
ment from plasmid pG/hER [29] were introduced into the BamHI site
of the yeast expression vector pG-1 [30] to yield the plasmid pG1/
Cdc37. The PCR product was also introduced into the BamHI-SacI of
plasmid pSP73 (Promega). To obtain construct pGEX2/CDC37 for
expression of a glutathione-S-transferase (GST)/Cdc37 fusion protein,
BamHI-EcoRI and EcoRI-EcoRI fragments from pSP73/CDC37 were
introduced into BamHI-EcoRI sites of the bacterial expression vector
pGEX2T (Pharmacia). The recombinant pYes/GST.Cdc37 for galac-
tose-inducible expression of the same fusion protein in yeast contains
the GST coding sequences as a SacI-BamHI fragment linked to the
above-mentioned CDC37 fragments in pYES2.0 (Invitrogen). Re-
combinant pYesADE2/HA-Ste11 is identical to plasmid pYes/HA-
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Ste11 [28] except that the expression vector pYesADE2 (a gift from
M. Strubin, University of Geneva) contains a substitution of the
marker ADE2 for URA3. Plasmids pYes/Ste11vN.GST, pYes/
Ste11vN, p2U/GST-2 and p2U/Hsp82.GST have been described pre-
viously [28,31].
2.2. Yeast strains
Strain DP007 was made by mating of strain 8A7 (MATK cdc37-34
leu2 lys2 trp1 ura3) ([24]) with wild-type strain RMY326 (MATa his3
leu2-3,112 trp1-1 ura3-52). After sporulation and tetrad dissection,
spores were tested for the cdc37-34 phenotype (temperature sensitiv-
ity). A MATa cdc37-34 spore was selected as DP007.
2.3. Growth arrest induced by K-factor or by Ste11vN expression
To monitor the cell cycle arrest in response to K-factor, cells were
diluted to a density of 1.2U107 cells/ml and streaked or spotted onto
YEPD plates containing 10 mM Na-citrate pH 4.3 and, where indi-
cated, 10 WM K-factor (Bachem, Switzerland), and incubated at 32‡C.
For the Ste11vN-induced growth arrest, the two strains, RMY326
and DP007, were transformed with plasmids pYES2.0, pYes/Ste11vN
or pYes/Ste11vN.GST, and single colonies were streaked on plates
containing glucose or galactose as carbon sources. The plates were
incubated at 30‡C for several days.
2.4. GST pull-down experiments
GST pull-down experiments were performed as follows: yeast cells
(strains 8A7 or RMY326 with plasmids pYes/Ste11vN.GST, p2U/
GST-2, p2U/Hsp82.GST, or pYes/GST.Cdc37 and pYesADE2/HA-
Ste11), where appropriate induced with galactose by overnight incu-
bation, were washed once with water containing 1 mM dithiothreitol
(DTT) and 1 mM PMSF, and once with TEG (25 mM Tris^HCl pH
7.4, 15 mM EGTA, 10% glycerol, 1 mM DTT, 1 mM PMSF, 3 Wg/ml
chymostatin, 1.5 Wg/ml pepstatin A, 0.75 Wg/ml leupeptin, 3.8 Wg/ml
antipain) containing 150 mM NaCl. Cell pellets were then resus-
pended in a small volume of the same bu¡er and broken with glass
beads by two 30 s pulses at maximum speed in a Mini-BeadBeater-8
(Biospec, Bartlesville) at 4‡C. After centrifugation at 15’000 rpm in a
table top centrifuge at 4‡C, the supernatant was quantitated and ad-
justed to 0.1% Triton X-100. Glutathione-Sepharose beads (Pharma-
cia) were added to the extracts, tumbled for 30 min at 4‡C, washed
three times with TEG containing 150 mM NaCl, 0.1% Triton X-100
and twice with TEG with 0.1% Triton X-100. Bound proteins were
eluted with 7.5 mM reduced glutathione in 50 mM Tris^HCl pH 8.0,
concentrated by TCA precipitation, resuspended in SDS-sample bu¡-
er and separated by 10% SDS^PAGE.
The recombinant proteins GST and GST-Cdc37 were expressed in
the Escherichia coli strain XL1-Blue (Stratagene) and extracted in a
phosphate-bu¡ered saline bu¡er (PBS) with 1 mM DTT, 1 mM
PMSF, 3 Wg/ml chymostatin, 1.5 Wg/ml pepstatin A, 0.75 Wg/ml leu-
peptin and 3.8 Wg/ml antipain by sonication after induction of protein
synthesis with 1 mM of isopropylthio-L-galactoside. After centrifuga-
tion at 15’000 rpm in a table top centrifuge at 4‡C, the supernatants
were adjusted to 0.1% Triton X-100, glutathione beads were added
and the samples were tumbled for 30 min at 4‡C. The beads (with
about 20 Wg of GST.Cdc37 or 80 Wg of GST) were washed three times
with PBS and once with TEG. 3 mg of yeast protein extract from
wild-type strain RMY326 was added to each sample and incubated
for 2 h at 4‡C with agitation. The beads were then washed three times
with TEG, bound proteins were eluted and processed as described
above.
2.5. Immunoblot experiments
After SDS^PAGE and transfer of proteins to nitrocellulose mem-
branes, the membranes were blocked with Tris-bu¡ered saline, 0.05%
Tween-20 (TBST) containing 5% (w/v) milk powder and probed with
appropriate antibodies in TBST+milk powder at room temperature
for 1 h. Mouse anti-GST monoclonal (Santa Cruz), chicken anti-
Hsp82 [29] and mouse monoclonal anti-Cdc37 antibodies (a gift
from A.J. Caplan, Mount Sinai, New York, USA) were all diluted
1:1000. Mouse monoclonal anti-HA antibody (a gift from K. Matter,
University of Geneva) was diluted 1:100. Membranes were washed
three times for 10 min with TBST. The secondary antibodies were
alkaline phosphatase-conjugated anti-chicken (Promega) and horse-
radish peroxidase-conjugated anti-mouse antibodies (Cappel). They
were incubated in TBST+milk powder at room temperature for 1 h.
After three washes with TBST, the blots were developed either with
the NBT/BCIP reagent for alkaline phosphatase or with the enhanced
chemiluminescence reagent (Pierce) for horseradish peroxidase.
2.6. In vitro protein kinase assays
After the GST pull-down, the beads with Ste11vN.GST expressed
in the cdc37 strain 8A7, complemented or not with pG1/Cdc37, were
incubated with 10 WCi of [Q-32P]ATP, at a ¢nal concentration of 20
WM ATP in kinase bu¡er (20 mM Tris^HCl pH 7.5, 50 mM KCl, 10
mM MgCl2 and 0.5% glycerol) for 20 min at 30‡C. After washing the
beads several times with kinase bu¡er, bound proteins were resus-
pended with SDS-sample bu¡er and separated by SDS^PAGE. After
transfer to a nitrocellulose membrane, an autoradiography was car-
ried out, and then an immunoblotting experiment with an anti-GST
antibody. Autoradiograph and nitrocellulose ¢lter were scanned to
quantitate the bands with the software ScanAnalysis (Biosoft, Cam-
bridge, UK).
3. Results
3.1. Cdc37 required for Ste11-mediated signaling
Several temperature-sensitive cdc37 alleles have been iso-
lated [1,2,24], which facilitate the functional analysis of this
essential gene. We tested di¡erent cdc37 strains for their abil-
ity to arrest growth in response to the mating pheromone K-
factor. Whereas the cdc37-1 allele supports the pheromone-
induced growth arrest at permissive temperature (data not
shown), the more severely defective cdc37-34 allele does not
(Fig. 1A). The former result is consistent with the observation
that mating and induction of the expression of the phero-
mone-induced FUS1 gene are normal in strains with the
cdc37-1 allele [32]. The failure of the cdc37-34 strain DP007
to respond to K-factor is a speci¢c defect since it can be sup-
pressed by the introduction of the wild-type CDC37 gene.
Note that this signaling defect correlates with impaired, albeit
not completely defective, mating (data not shown).
In a ¢rst attempt towards determining the step(s) of the
pheromone pathway (see Fig. 4) that is dependent on
Cdc37, we assayed growth arrest induced by a constitutively
active Ste11 mutant expressed under the control of a galac-
tose-inducible promoter. It has been shown that the deletion
of the amino-terminal regulatory domain of Ste11 (Ste11vN)
results in constitutive activation of this kinase [33]. When the
expression of Ste11vN is induced by plating the cells on ga-
lactose, their growth is inhibited. Since Ste11 is also involved
in several other signaling pathways [26,27], the growth inhib-
itory e¡ect results from the combined activation of the pher-
omone and osmoregulatory pathways [34]. Fig. 1B shows that
Ste11vN fused to the N-terminus of GST (Ste11vN.GST) is
as e⁄cient as the unfused version at eliciting this response in a
wild-type strain. This tagged version of Ste11vN greatly facil-
itates the biochemical analysis (see below), and it is there-
fore used in most subsequent experiments. The strain DP007
with the cdc37-34 allele fails to be growth-arrested by
Ste11vN.GST unless it is complemented by the wild-type
CDC37 gene (Fig. 1C). The same pattern was observed with
the original cdc37-34 strain 8A7, which has the opposite mat-
ing type (MATK) (data not shown). Thus, these experiments
showed that the requirement for Cdc37 is independent of
mating type and possibly at the level of Ste11 or downstream
of it.
3.2. Accumulation and maturation of Ste11 are defective in a
cdc37-34 background
We have previously reported that the accumulation of Ste11
FEBS 23280 28-1-00
T. Abbas-Terki et al./FEBS Letters 467 (2000) 111^116112
is reduced in strains in which the molecular chaperone Hsp90
is altered genetically [28]; this e¡ect can be mimicked phar-
macologically by blocking Hsp90 function with the benzoqui-
none ansamycin Macbecin I (data not shown). Moreover, the
vertebrate tyrosine kinase pp60vÿsrc is produced at lower levels
and is less active upon expression in a cdc37-34 yeast strain at
permissive temperature [24]. We therefore decided to examine
the levels and the activity of Ste11vN.GST expressed in strain
8A7 with and without wild-type CDC37. Fig. 2A shows that
the steady-state level of Ste11vN.GST expressed from a ga-
lactose-inducible promoter is reduced in the mutant strain.
The levels of other proteins, for example of endogenous
Hsp82 or of L-galactosidase also expressed from a galactose-
inducible promoter, were not a¡ected by the mutation (data
not shown). Since Ste11vN.GST is expressed from a heterol-
ogous promoter, this suggests that it might be the degradation
of Ste11vN.GST that is increased in the cdc37-34 strain.
We next performed an in vitro kinase assay with
Ste11vN.GST pulled down from yeast extracts with gluta-
thione beads (Fig. 2B). Phosphorylation of Ste11vN.GST is
reduced 8-fold in the absence of wild-type Cdc37. Thus, both
accumulation of Ste11vN.GST and relative phosphorylation
of what does accumulate are reduced in the mutant strain.
These ¢ndings are consistent with the idea that Cdc37 is re-
quired for the accumulation and maturation not only of the
exogenously expressed Ste11vN.GST, but also of the endog-
enous wild-type Ste11 protein, and that these defects are re-
sponsible for the signaling defect described above.
3.3. Pairwise complexes of Cdc37, Ste11 and Hsp90
Several lines of evidence indicated that Ste11 might associ-
ate with both Cdc37 and Hsp90. We had previously shown
that Ste11 forms complexes with Hsp90 in yeast [28], and the
vertebrate Ste11 equivalent Raf-1 had been demonstrated to
form complexes with both Cdc37 and Hsp90 [25]. We there-
fore examined the presence of pairwise complexes in wild-type
cells with GST pull-down experiments. Fig. 3A shows that
Ste11vN.GST expressed in yeast is associated with endoge-
nous Cdc37 whereas GST only pulls down background levels.
In the converse experiment, a GST-Cdc37 fusion protein, but
not GST alone, pulls down exogenously expressed epitope-
tagged full-length Ste11 (Fig. 3B). This demonstrates that
the association of Cdc37 and Ste11 is not restricted to the
N-terminally truncated Ste11vN. Moreover, the yeast Hsp90
isoform Hsp82, expressed as a GST fusion protein in yeast,
but not GST alone, pulls down endogenous Cdc37 (Fig. 3C).
To characterize the latter interaction further, we examined
whether yeast Hsp90 could be retained by a recombinant
GST-Cdc37 fusion protein from a total yeast extract. Note
that such an N-terminally tagged Cdc37 can be fully func-
tional as the same fusion protein is able to complement a
cdc37-34 strain at non-permissive temperature (data not
Fig. 2. Ste11vN.GST protein levels and Ste11 phosphorylation are
defective in a cdc37 strain. (A) Ste11vN.GST protein levels:
Ste11vN.GST expression was induced by galactose in the cdc37
strain 8A7 complemented or not with wild-type Cdc37 (vector pG1/
Cdc37). The same amounts of protein extract (30 Wg) were analyzed
by immunoblotting with an anti-GST antibody; equal loading was
con¢rmed by Ponceau red staining of the membrane. (B) Ste11
phosphorylation: after a pull-down of Ste11vN.GST from extracts
prepared from the same yeast transformants, the puri¢ed proteins
on the beads were subjected to an in vitro kinase assay. After SDS^
PAGE and transfer to a nitrocellulose membrane, an autoradiogra-
phy was performed prior to detection of Ste11vN.GST by immuno-
blotting with an anti-GST antibody. Note that 4-fold more pulled
down Ste11vN.GST was loaded for the sample in the second lane
(-wt Cdc37) to facilitate quantitation of the reduced 32P incorpora-
tion.
Fig. 1. CDC37 is required for growth arrest induced by pheromone
and by the constitutive kinase Ste11vN. (A) Pheromone-induced
growth arrest is defective in a cdc37 yeast strain. Transformants of
strain DP007 (MATa cdc37-34), containing either the episomic ex-
pression vector for wild-type Cdc37 (pG1/Cdc37) or the empty ex-
pression vector pG-1, were streaked on plates without or with 10
WM of K-factor, and incubated at 32‡C for 3 and 5 days, respec-
tively. (B) A GST fusion protein of Ste11vN (Ste11vN.GST) indu-
ces growth arrest as well as Ste11vN. Transformants of the wild-
type strain RMY326 with galactose-inducible expression of Ste11vN
or Ste11vN.GST were plated on glucose and galactose plates (re-
pressed and induced conditions, respectively) and grown for 4 days
at 30‡C. (C) Ste11vN.GST fails to induce growth arrest in the
cdc37 strain DP007. Vectors and assays were as in (A) and (B);
plates were incubated at 30‡C for 5 days. In all three experiments,
2^3 independent transformants were tested.
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shown). As can be seen in Fig. 3D, GST-Cdc37 speci¢cally
pulls out the two Hsp90 isoforms Hsp82 and Hsc82. Since no
other band of similar intensity is visible in the Coomassie-
stained gel, we tentatively conclude that the interaction be-
tween Cdc37 and yeast Hsp90 is direct. Due to the severely
reduced levels in a cdc37-34 strain of both the mutant Cdc37
itself [35] and its client Ste11vN.GST (see above), we have not
been able to assess the e¡ects of the mutation on all relevant
pairwise complexes although Ste11-Hsp90 complexes still
seem to form (data not shown).
4. Discussion
We have shown that CDC37 is required for pheromone
signaling, growth arrest induced by a constitutive Ste11 ki-
nase, and accumulation and activity of Ste11. Moreover, we
have demonstrated that Cdc37 and Ste11 form complexes.
Taken together, these results argue very strongly that Ste11
function depends on Cdc37. Whether all signaling pathways
that require Ste11 [26,27] are defective remains to be deter-
mined. However, this seems highly likely in view of the low
level and activity of Ste11 in a cdc37 mutant strain. Hence,
Cdc37 might be required for pheromone signaling as well as
the osmoregulatory response and the response to low nitrogen
levels.
Several observations support the conclusion that Ste11 is a
direct target of Cdc37: (i) two di¡erent epitope-tagged ver-
sions of Ste11 associate with Cdc37; (ii) accumulation and
phosphorylation of a Ste11-GST fusion protein are reduced;
(iii) Hsp90, another molecular chaperone that is required for
Fig. 3. Biochemical interactions between Cdc37, Ste11 and Hsp90. (A) Ste11vN.GST pulls down Cdc37. A GST pull-down experiment was per-
formed with yeast extracts from the wild-type strain RMY326 expressing GST or Ste11vN.GST (induced with galactose). GST and
Ste11vN.GST, and endogenous Cdc37 were revealed by immunoblotting the same membrane with anti-GST and anti-Cdc37 antibodies, respec-
tively. (B) GST.Cdc37 pulls down HA-tagged full-length Ste11. Expression of HA-Ste11 and GST.Cdc37 or GST was induced in RMY326
transformants with galactose. 50 Wg of total yeast protein extract was loaded in lanes labelled ‘input’; lanes labelled ‘pull-down’ contain pro-
teins retained by a GST pull-down experiment with 2.4 mg of total yeast protein extract. After transfer, the membrane was stained with Pon-
ceau red to reveal total protein and subsequently immunoblotted with an anti-HA antibody. M, molecular weight marker with bands at 180,
116, 84, 58, 48, 36 and 26 kDa. (C) Hsp82.GST pulls down endogenous Cdc37. The GST pull-down experiment was done as above except that
Hsp82.GST and GST were expressed in medium with glucose as carbon source. (D) Hsp90 is retained by recombinant GST.Cdc37 but not by
GST. The recombinant puri¢ed GST proteins were incubated with 3 mg of total yeast protein extract (lanes marked +). Retained proteins were
revealed by Coomassie blue staining (top panel) and immunoblotting with anti-Hsp82 antibodies (bottom panel). The Hsp90 band corresponds
to the two yeast isoforms Hsc82 and Hsp82; it resolves into a double band visible by Coomassie staining below the GST.Cdc37 input upon
more extensive electrophoresis of a smaller amount of total protein (small panel on the right).
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Ste11 function [28], associates with Cdc37. These results par-
allel those obtained in the vertebrate system. The vertebrate
Ste11 equivalent Raf-1, with its catalytic domain, binds di-
rectly to human p50Cdc37 [20]. Interaction of Raf-1 with
Hsp90 appears to be both direct and indirect through the
formation of a ternary complex with p50Cdc37 [25]. Raf-1 func-
tion and signaling are blocked by a truncated version of
p50Cdc37 that is unable to recruit Raf-1 into a ternary complex
with Hsp90 [25]. Although we have been able to demonstrate
pairwise associations of Cdc37, Ste11 and Hsp90 in the yeast
system (Fig. 4), novel approaches need to be developed to
determine the stoichiometry and dynamics of these complexes,
in general, and whether the three proteins form a ternary
complex, in particular.
Our ¢ndings are consistent with the idea developed for the
metazoan systems [25] that the two molecular chaperones
Hsp90 and Cdc37 coordinately, and perhaps only transiently,
intervene in the folding of newly synthesized Ste11 and/or in
directing additional cofactors to Ste11. When Cdc37 or Hsp90
functions are defective, Ste11 may not properly fold or asso-
ciate with other factors. As a consequence, it does not become
functional and is eventually degraded more rapidly (see also
[28]). Allele-speci¢c e¡ects, such as those observed with Ste11
(see above and [28]), have been reported for pp60vÿsrc ex-
pressed in cdc37 [24] and hsp90 [7,36^38] mutant yeast strains.
Indeed, the cdc37-34 allele was selected for as a mutation that
relieves the toxicity of overexpressed pp60vÿsrc in yeast. De-
creases in accumulation and speci¢c activity of pp60vÿsrc both
contribute to reduce the toxicity in cdc37-34 cells even at
permissive temperature [24]. In contrast, cdc37-1 is a milder
allele that is associated with resistance to both pp60vÿsrc [24]
and Ste11vN at permissive temperature. We have recently
discovered that the eIF2K kinase Gcn2 is an Hsp90 substrate
and that the general amino acid control, a Gcn2-dependent
response to limiting levels of amino acids, is defective in both
cdc37-1 and cdc37-34 strains [39]. Whereas reduced accumu-
lation and functional ‘maturation’ was also reported for
Cdc28 in a cdc37-1 mutant strain [2], Cdc37 defects may not
lead to increased degradation of all Cdc37 client proteins.
Mps1, another putative Cdc37 client protein in yeast, accu-
mulates to the same levels but its kinase activity is markedly
reduced [5].
It is interesting to compare Cdc37 with Hsp90. They are
both essential for viability, biochemically and genetically as-
sociated with a whole panel of kinases, and they have very
similar chaperone activities in vitro (reviewed in [21^23]).
However, they cannot replace each other in yeast or in Dro-
sophila except perhaps for a subset of substrates such as
pp60vÿsrc expressed in yeast [7]. Whereas Hsp90 is very highly
conserved with 60% sequence identity between human and
yeast, Cdc37 is not (only 20%). It is conceivable that higher
order structural elements of the Cdc37-Hsp90 interface are
conserved. Although Cdc37 appears to bind to Hsp90 directly
both in vertebrates [20] and in yeast (see above), Cdc37 and
Hsp90 certainly do not always come together. Hsp90, the
more abundant partner, associates with several other cofac-
tors whose binding to Hsp90 sterically prevents the binding of
p50Cdc37 [20]. As a result, Hsp90 in association with these
other cofactors is likely to have a distinct set of client pro-
teins. It remains to be seen whether the converse is true as
well, whether there are Cdc37 clients that do not need Hsp90.
Unlike Ste11 [28] and Gcn2 [39], Cdc28, Kin28 and Mps1,
although genetically linked to Cdc37, have not been shown
to form complexes with either Cdc37 or Hsp90 in yeast [2,5,6].
To explore further the similarities and di¡erences between
Cdc37 and Hsp90, it will be interesting to determine whether
SSF1, HCH1 and CNS1, which have been discovered as al-
lele-speci¢c suppressors of temperature-sensitive hsp90 muta-
tions [40], are able to suppress cdc37 mutations. It is note-
worthy, though, that CDC37 itself is the only gene that we
have been able to recover as a high-copy suppressor of cdc37
(data not shown). More proteins that interact with Cdc37
need to be identi¢ed to assess whether it acts ‘solely’ as one
of several Hsp90 co-chaperones.
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